This drug is currently taken by one in four people to reduce cholesterol in the blood and thus prevent cardiovascular diseases. URV-IISPV researcher Lluís Masana has coordinated a study carried out at 19 Catalan hospitals during the first wave of the pandemic
Search results for: coronavirus
The Learning and Research Resources Centre (CRAI) is only open for loans and the URV’s sporting activities have been postponed
The new measure agreed by the Catalan universities will not affect research activity
This has been established in the URV’s Contingency Plan for the 2020-21 academic year, which stipulates how all members of the URV community must act in order to prevent the spread of the disease on its campuses
All courses will be taught following a blended format and priority will be given to the face-to-face activities of first-year bachelor’s degrees
A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”
31/03/2020
URV information on COVID-19
All buildings and facilities are closed until further notice. Teaching and assessments will continue at a distance, as far as possible (last update: 03/04/2020)
Seven 3D printers from different departments at the University have started to produce equipment, in particular face masks, which will be distributed to healthcare staff throughout the Tarragona region
The researcher from the Department of Computer Engineering and Mathematics, Àlex Arenas, is one of the signatories of the document alongside Oriol Mitjà
This is not just a health crisis. It is a social and universal crisis